GSK Plc (Brazil) Today
| G1SK34 Stock | BRL 41.07 0.29 0.71% |
Performance0 of 100
| Odds Of DistressLess than 9
|
GSK Plc is trading at 41.07 as of the 30th of November 2024, a 0.71 percent increase since the beginning of the trading day. The stock's open price was 40.78. GSK Plc has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for GSK plc are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 31st of October 2024 and ending today, the 30th of November 2024. Click here to learn more.
Moving together with GSK Stock
Moving against GSK Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
GSK Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. GSK Plc's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding GSK Plc or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Drug Manufacturers-General, Healthcare (View all Sectors) |
GSK plc (G1SK34) is traded on Sao Paulo Exchange in Brazil and employs 10 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 388.07 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate GSK Plc's market, we take the total number of its shares issued and multiply it by GSK Plc's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. GSK plc operates under Healthcare sector and is part of Drug Manufacturers-General industry. The entity has 4.09 B outstanding shares.
GSK Plc generates positive cash flow from operations, but has no cash available
Check GSK Plc Probability Of Bankruptcy
GSK plc Risk Profiles
Although GSK Plc's alpha and beta are two of the key measurements used to evaluate GSK Plc's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.35 | |||
| Standard Deviation | 1.93 | |||
| Variance | 3.73 | |||
| Risk Adjusted Performance | (0.08) |
GSK Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in GSK Plc without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Fundamental Analysis Now
Fundamental AnalysisView fundamental data based on most recent published financial statements |
| All Next | Launch Module |
GSK Plc Corporate Management
Elected by the shareholders, the GSK Plc's board of directors comprises two types of representatives: GSK Plc inside directors who are chosen from within the company, and outside directors, selected externally and held independent of GSK. The board's role is to monitor GSK Plc's management team and ensure that shareholders' interests are well served. GSK Plc's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, GSK Plc's outside directors are responsible for providing unbiased perspectives on the board's policies.
| David Redfern | Chief Officer | Profile | |
| Diana Conrad | Chief Officer | Profile | |
| Emma Walmsley | CEO Director | Profile | |
| Sally Jackson | VP Office | Profile | |
| Iain Mackay | CFO Director | Profile | |
| James Ford | Sr Compliance | Profile | |
| Shobie Ramakrishnan | Chief Officer | Profile |
Other Information on Investing in GSK Stock
GSK Plc financial ratios help investors to determine whether GSK Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in GSK with respect to the benefits of owning GSK Plc security.